HK1097188A1 - Alginate viscoelastic composition, method of use and package - Google Patents

Alginate viscoelastic composition, method of use and package

Info

Publication number
HK1097188A1
HK1097188A1 HK07104246.7A HK07104246A HK1097188A1 HK 1097188 A1 HK1097188 A1 HK 1097188A1 HK 07104246 A HK07104246 A HK 07104246A HK 1097188 A1 HK1097188 A1 HK 1097188A1
Authority
HK
Hong Kong
Prior art keywords
alginate
viscoelastic composition
package
viscoelastic
dispersive
Prior art date
Application number
HK07104246.7A
Other languages
English (en)
Inventor
Dharmendra Jani
Joseph C Salamone
Original Assignee
Bausch & Lomb Inc One Bausch &
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb Inc One Bausch & filed Critical Bausch & Lomb Inc One Bausch &
Publication of HK1097188A1 publication Critical patent/HK1097188A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
HK07104246.7A 2004-02-26 2007-04-23 Alginate viscoelastic composition, method of use and package HK1097188A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54785504P 2004-02-26 2004-02-26
PCT/US2005/005800 WO2005082333A1 (en) 2004-02-26 2005-02-24 Alginate viscoelastic composition, method of use and package

Publications (1)

Publication Number Publication Date
HK1097188A1 true HK1097188A1 (en) 2007-06-22

Family

ID=34910952

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104246.7A HK1097188A1 (en) 2004-02-26 2007-04-23 Alginate viscoelastic composition, method of use and package

Country Status (11)

Country Link
US (1) US20050209606A1 (de)
EP (1) EP1720518B1 (de)
JP (1) JP2007525515A (de)
KR (1) KR20070001970A (de)
CN (1) CN1921833A (de)
AT (1) ATE439121T1 (de)
AU (1) AU2005216946B2 (de)
CA (1) CA2557323A1 (de)
DE (1) DE602005015936D1 (de)
HK (1) HK1097188A1 (de)
WO (1) WO2005082333A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
US7659259B2 (en) 2006-12-21 2010-02-09 Bausch & Lomb Incorporated Method of treating inflammation of the eye
DE112008002511T5 (de) * 2007-09-18 2010-07-15 LenSx Lasers, Inc., Aliso Viejo Verfahren und Vorrichtungen für integrierte Kataraktchirurgie
DK2268142T3 (en) * 2007-11-27 2017-05-22 Algipharma As USING ALGINATED OLIGOMERS TO FIGHT BIOFILM
BRPI0915116A2 (pt) * 2008-06-12 2016-02-10 Novartis Ag sistema de geleificação in situ como aplicação sustentada para a parte frontal do olho
FR2968996B1 (fr) * 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
US20160325009A1 (en) * 2014-01-02 2016-11-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Ophthalmic viscosurgical device
KR102035937B1 (ko) * 2018-07-16 2019-10-23 가톨릭대학교 산학협력단 백내장 수술용 의료 기구

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675113A (en) * 1984-11-28 1987-06-23 University Patents, Inc. Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5200180A (en) * 1987-06-26 1993-04-06 Christian Bannert Pharmaceutical composition for the treatment of the human eye
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US5461081A (en) * 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
US5792099A (en) * 1995-02-14 1998-08-11 Decamp; Dennis Syringe and cannula for insertion of viscoelastic material into an eye and method of using same
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
AUPQ228199A0 (en) * 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
US7060297B2 (en) * 2000-11-06 2006-06-13 Alcon, Inc. Carrageenan viscoelastics for ocular surgery
CN100467066C (zh) * 2001-08-10 2009-03-11 东丽株式会社 一种通过包含琼脂增强了眼用药物渗透性的滴眼液
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US7128928B2 (en) * 2002-02-22 2006-10-31 Pharmacia Corporation Ophthalmic formulation with novel gum composition
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions

Also Published As

Publication number Publication date
DE602005015936D1 (de) 2009-09-24
WO2005082333A1 (en) 2005-09-09
EP1720518B1 (de) 2009-08-12
CN1921833A (zh) 2007-02-28
AU2005216946A1 (en) 2005-09-09
ATE439121T1 (de) 2009-08-15
KR20070001970A (ko) 2007-01-04
EP1720518A1 (de) 2006-11-15
AU2005216946B2 (en) 2008-10-09
CA2557323A1 (en) 2005-09-09
JP2007525515A (ja) 2007-09-06
US20050209606A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
HK1097188A1 (en) Alginate viscoelastic composition, method of use and package
IL229778A0 (en) Antibodies against ir-igf, their use and preparations that include them
TW200738817A (en) Blends of biopolymers with acrylic copolymers
TW200732349A (en) Anti-OX40L antibodies and methods using same
WO2006083936A3 (en) Anti-ephb2 antibodies and methods using same
WO2004078120A3 (en) Collagen compositions and biomaterials
PT2308942T (pt) Uso de composições de agente de sopro compreendendo trans-1,3,3,3-tetrafluoropropeno (trans-hfo-1234ze).
SG166797A1 (en) Gear oil composition
TW200714294A (en) Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
WO2004092135A3 (en) Substituted benzosulphonamide as potentiators of glutamate receptors
RS20060320A (en) Substituted indazole-o-glucosides
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
IL171990A0 (en) Novel 8-aza-bicyclo[3,2,1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1927587A3 (de) Konjugierte Dienamide, Herstellungsverfahren dafür, Zusammensetzungen damit und Anwendungen davon
WO2006056695A8 (fr) Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
WO2004112786A3 (en) Gaboxadol for treating depression and other affective disorders
MY145705A (en) Adhesive composition and method
WO2007061888A8 (en) Degradable chewing gum
AU2003297568A1 (en) Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
TW200712129A (en) Silicone material having outstanding viscosity stability

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140224